Antisense mapping of the MOR-1 opioid receptor clone: Modulation of hyperphagia induced by DAMGO

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1402-1407

  Leventhal, Liza ^a   Stevens, Lesley B ^a   Rossi, Grace C ^b   Pasternak, Gavril W ^b   Bodnar, Richard J ^a,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA FUNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR MOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXON; HYPERPHAGIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RAT;

ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; HYPERPHAGIA; MALE; NALTREXONE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 0030924181     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ADAMS, J. U., CHEN, X., DERIEL, J. K., ADLER, M. W. AND LIU-CHEN, L. Y.; Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats. Brain Res. 667: 129-132, 1994.
2. ARJUNE, D., STANDIFER, K. M., PASTERNAK, G. W. AND BODNAR, R. J.: Reduction by central β-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535: 101-109, 1990.
3. BADIANI, A., LEONE, P., NOEL, M. B. AND STEWART, J.: Ventral tegmental area opioid mechanisms and modulation of ingestive behavior. Brain Res. 670: 264-276, 1995.
4. BAKSHI, V. P. AND KELLEY, A. E.: Striatal regulation of morphine-induced hyperphagia: An anatomical mapping study. Psychopharmocology 111: 207-214, 1993.
5. BILSKY, E. J., BERNSTEIN, R. N., PASTERNAK, G. W., HRUBY, V. J., PATEL, D., PORRECA, F. AND LAJ, J.: Selective inhibition of [D-Ala2,Glu4] deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci. 55: PL37-43, 1994.
6. BODNAR, R. J.: Opioid receptor subtype antagonists and ingestion. In Drug Receptor Subtypes and Ingestive Behaviour, ed. by S. J. Cooper and P. J. Clifton, pp. 127-146, Academic Press, London, 1996.
7. BODNAR, R. J., GLASS, M. J., RAGNAUTH, A. AND COOPER, M. L.: General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700: 205-212, 1995.
8. BODNAR, R. J., PAUL, D. AND PASTERNAK, G. W.: Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus: Studies with the partial mu-1 agonist ethylketocyclazocine. Brain Res. 558: 224-230, 1991.
9. BODNAR, R. J., WILLIAMS, C. L., LEE, S. J. AND PASTERNAK, G. W.: Role of mu1 opiate receptors in supraspinal opiate analgesia: A microinjection study. Brain Res. 447: 25-34, 1988.
10. CADOR, M., KELLEY, A. E., LEMOAL, M. AND STINUS, L.: Ventral tegmental area infusion of substance P, neurotensin and enkephalin: Differential effects on feeding behavior, Neuroscience 18: 659-669, 1986.
11. CHEN, X. H., ADAMS, J. U., GELLER, E. B., DERIEL, J. K., ADLER, M. W. AND LIU-CHEN, L. Y.: An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats. Eur. J. Pharmacol. 275: 105-108, 1995.
12. CHIEN, C. C., BROWN, G. P., PAN, Y. X. AND PASTERNAK, G. W.: Blockade of U50488H analgesia by antisense oligodeoxynucleotides to a kappa opioid receptor. Eur. J. Pharmacol. 253: R7-8, 1994.
13. COLE, J. L., LEVENTHAL, L., PASTERNAK, G. W., BOWEN, W. D. AND BODNAR, R. J., Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678: 168-176, 1995.
14. DOYLE, T. G., BERRIDGE, K. C. AND GOSNELL, B. A.: Morphine enhances hedonic taste palatability in rats. Pharmacol. Biochem. Behav. 46: 745-749, 1993.
15. EVANS, C., KEITH, D., MORRISON, H., MAGENDZO, K. AND EDWARDS, R.: Cloning of a delta-opioid receptor by functional expression. Science (Wash, DC) 258: 1952-1955, 1992.
16. FANG, F. G., FIELDS, H. L. AND LEE, N. M.: Action at the mu receptor is sufficient to explain supraspinal analgesic effect of opiates. J. Pharmacol. Exp. Ther. 238: 1039-1044, 1986.
17. GOSNELL, B. A., KRAHN, D. D. AND MAJCHRZAK, M. J.: The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol. Biochem. Behav. 37: 207-212, 1990.
18. GOSNELL, B. A. AND LEVINE, A. S.: Stimulation of ingestive behaviour by preferential and selective opioid agonists. In Drug Receptor Subtypes and Ingestive Behaviour, ed. by S. J. Cooper and P. G. Clifton, pp. 147-166. Academic Press, London, 1996.
19. GOSNELL, B. A., LEVINE, A. S. AND MORLEY, J. E.: The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci. 38: 1081-1088, 1986a.
20. GOSNELL, B. A., MORLEY, J. E. AND LEVINE, A. S.: Opioid-induced feeding: Localization of sensitive brain sites. Brain Res. 369: 177-184, 1986b.
21. KIEFFER, B., BEFORT, K., GAREIAUX-RUFF, C. AND HIRTH, C.: The delta-opioid receptor: Isolation of cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. (U.S.A.) 89: 12048-12052, 1992.
22. KOCH, J. E. AND BODNAR, R. J.: Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res. 657: 191-201, 1994.
23. KOCH, J. E., GLASS, M. J., COOPER, M. L. AND BODNAR, R. J.: Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 66: 951-957, 1995.
24. LAI, J., BILSKY, E. J., ROTHMAN, R. B. AND PORRECA, F.: Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta2-agonist antinociception. Neuroreport 5: 1049-1052, 1994.
25. LEVENTHAL, L., COLE, J. L., ROSSI, G. C., PAN, Y. X., PASTERNAK, G. W. AND BODNAR, R. J.: Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats. Brain Res. 719: 78-84, 1996.
26. LEVINE, A. S., GRACE, M. AND BILLINGTON, C. J.: β-funaltrexamine (β-FNA) decreases deprivation and opioid-induced feeding. Brain Res. 562: 281-284, 1991.
27. MAJEED, N. H., PRZEWLOCKA, B., WEDZONY, K. AND PRZEWLOCKI, R.: Stimulation of food intake following opioid microinjection into the nucleus accumbens septi n rats. Peptides 7: 711-716, 1986.
28. MARKS-KAUFMAN, R.: Increased fat consumption induced by morphine administration in rats. Pharmacol. Biochem. Behav. 16: 949-955, 1982.
29. MARKS-KAUFMAN, R. AND KANAREK, R. B.: Morphine selectively influences macronutrient intake in the rat. Pharmacol. Biochem. Behav. 12: 427-430, 1980.
30. MORLEY, J. E., LEVINE, A. S., YIM, G. K. W. AND LOWY, M. T.: Opioid modulation of appetite. Neurosci. Biobehav. Rev. 7: 281-305, 1983.
31. MUCHA, R. F. AND IVERSEN, S. D.: Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 397: 214-224, 1986.
32. NOEL, M. B. AND WISE, R. A.: Ventral tegmental injections of morphine but not U50488H enhance feeding in food-deprived rats. Brain Res. 632: 68-73, 1993.
33. NOEL, M. B. AND WISE, R. A.: Ventral tegmental injections of a selective mu or delta opioid enhance feeding in food-deprived rats. Brain Res. 673: 304-312, 1995.
34. PASTERNAK, G. W.: Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16: 1-18, 1993.
35. PASTERNAK, G. W., BODNAR, R. J., CLARK, J. A. AND INTURRISI, C. E.: Morphine-6β-glucuronide, a potent mu agonist. Life Sci. 41: 2845-2849, 1987.
36. PASTERNAK, G. W. AND STANDIFER, K. M.: Mapping of opioid receptors using antisense oligodeoxynucleotides: Correlating their molecular biology and pharmacology. Trends Pharmacol Sci. 16: 344-350, 1995.
37. PAUL, D., STANDIFER, K. M., INTURRISI, C. E. AND PASTERNAK, G. W.: Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251: 477-483, 1989.
38. PORTOGHESE, P. S., LARSON, D. L., SAYRE, L. M., FRIES, D. S. AND TAKEMORI, A. E.: A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23: 233-234, 1980.
39. ROSSI, G. C., BROWN, G. P., LEVENTHAL, L., YANG, K. AND PASTERNAK, G. W.: Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci. Lett. 216: 1-4, 1996.
40. ROSSI, G. C., LEVENTHAL, L., PAN, Y.-X., COLE, J., SU, W., BODNAR, R. J. AND PASTERNAK, G. W.: Differential inhibition of morphine and morphine-6β-glucuronide antinociception in the rat by antisense oligodeoxynucleotides against MOR-1. J. Pharmacol. Exp. Ther. 281: 109-114, 1997.
41. ROSSI, G. C., PAN, Y. X., BROWN, G. P. AND PASTERNAK, G. W.: Antisense mapping the MOR-1 receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Letters 369: 192-196, 1995a.
42. ROSSI, G. C., PAN, Y. X., CHENG, J. AND PASTERNAK, G. W.: Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci. 54: PL375-379, 1994.
43. ROSSI, G. C., STANDIFER, K. M. AND PASTERNAK, G. W.: Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci. Lett. 198: 99-102, 1995b.
44. RUEGG, H., HAHN, B., KOCH, J. E. AND BODNAR, R. J.: Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats. Brain Res. 635: 203-210, 1994.
45. SANGER, D. J. AND MCCARTHY, P. S.: Differential effects of morphine on food and water intake in food deprived and freely feeding rats. Psychopharmocology 72: 103-106, 1980.
46. SMITH, D. J., PEROTTI, J. M., CRISP, T., CABRAL, M. E. Y., LONG, J. T. AND SCALZITI, J. N.: The mu receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur. J. Pharmacol. 156: 47-54, 1988.
47. STANDIFER, K. M., CHIEN, C. C., WAHLSTEDT, C., BROWN, G. P. AND PASTERNAK, G. W.: Selective loss of delta opioid analgesia and binding by oligodeoxynucleotides to a delta opioid receptor. Neuron 12: 805-810, 1994.
48. TSENG, L. F., COLLINS, K. A. AND KAMPINE, J. P.: Antisense oligodeoxynucleotides to a delta-opioid receptor selectively block the spinal antinociception induced by delta-, but not mu- or kappa -opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258: R1-3, 1994.
49. UHL, G. R., CHILDERS, S. R. AND PASTERNAK, G. W.: An opiate receptor gene family reunion. Trends Neurosci. 17: 89-93, 1994.
50. UKAI, M. AND HOLTZMAN, S. G.: Effects of β-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153: 161-165, 1988.